SCHEMBL26884262

SCHEMBL26884262

COc1cccc2sc(NC(=O)c3ccn(C)n3)nc12

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 1/20 0.63
▸ DUSP3 P51452 3/20 0.62
▸ CHRM4 P08173 1/20 0.62
▸ MEN1 O00255 6/20 0.60
▸ KMT2A Q03164 6/20 0.60
▸ NPC1 O15118 4/20 0.60
▸ RAB9A P51151 4/20 0.60
▸ KDM4E B2RXH2 3/20 0.60
▸ ALDH1A1 P00352 3/20 0.60
▸ HPGD P15428 3/20 0.60
▸ TMIGD3 P0DMS9 1/20 0.60
▸ ADORA1 P30542 1/20 0.60
▸ PPARG P37231 1/20 0.60
▸ NPSR1 Q6W5P4 1/20 0.60
▸ NR2E3 Q9Y5X4 1/20 0.60
▸ NCOR2 Q9Y618 1/20 0.60
▸ CASP3 P42574 1/20 0.55
▸ SENP8 Q96LD8 1/20 0.55
▸ SENP6 Q9GZR1 1/20 0.55
▸ LMNA P02545 4/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26658545 0.79 NPC1 (0.67) DYRK1AMEN1KMT2ANPC1RAB9A
SCHEMBL3045307 0.79 DUSP3 (0.82) DYRK1ADUSP3CHRM4MEN1KMT2A
SCHEMBL15376502 0.78 DYRK1A (1.00) DYRK1ADUSP3CHRM4MEN1KMT2A
SCHEMBL20660046 0.78 DYRK1A (0.80) DYRK1ADUSP3CHRM4MEN1KMT2A
SCHEMBL3047328 0.78 DYRK1A (0.80) DYRK1ADUSP3CHRM4MEN1KMT2A
SCHEMBL23002439 0.78 RAB9A (0.66) MEN1KMT2ANPC1RAB9AALDH1A1
SCHEMBL3050805 0.77 DYRK1A (0.78) DYRK1ADUSP3CHRM4MEN1KMT2A
SCHEMBL14807633 0.77 DUSP3 (0.82) DYRK1ADUSP3CHRM4MEN1KMT2A
SCHEMBL20659925 0.76 DYRK1A (0.76) DYRK1ADUSP3CHRM4MEN1KMT2A
SCHEMBL3054015 0.76 DUSP3 (0.76) DYRK1ADUSP3CHRM4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382903-A1 SMALL MOLECULE MODULATORS OF GP130 SIGNALING PATHWAYS, TOPICAL FORMULATIONS AND METHOD OF USE THEREOF CARTHRONIX INC (US) 2023-11-30 — — US disclosed
US-20230382903-A1 SMALL MOLECULE MODULATORS OF GP130 SIGNALING PATHWAYS, TOPICAL FORMULATIONS AND METHOD OF USE THEREOF CARTHRONIX INC (US) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382903-A1 SMALL MOLECULE MODULATORS OF GP130 SIGNALING PATHWAYS, TOPICAL FORMULATIONS AND METHOD OF USE THEREOF STAT1, STAT3, STAT6 DYRK1A 2744/4885DUSP3 701/4885CHRM4 3137/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback